Related Experiment Video

Updated: Aug 24, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

[Effect of tobacco smoking on endothelial function in patients with coronary arteriosclerosis]

Rafał Poreba1, Anna Skoczyńska, Arkadiusz Derkacz

  • 1Katedra i Klinika Chorób Wewnetrznych, Zawodowych i Nadciśnienia Tetniczego AM we Wrocławiu.

Polskie Archiwum Medycyny Wewnetrznej
|April 20, 2004
PubMed

Insights

Cigarette smoking impairs endothelial function, lowering nitric oxide (NO) levels and increasing inflammation markers like interleukin-6 and sICAM in individuals with coronary artery atherosclerosis. This suggests smoking exacerbates vascular inflammation.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Biochemistry

Context:

  • Smoking is a primary risk factor for atherosclerosis and ischemic heart disease.
  • Endothelial dysfunction is a key pathological consequence of smoking.
  • This study investigates smoking's impact on endothelial function markers in patients with confirmed coronary atherosclerosis.

Purpose:

  • To assess the biochemical effects of cigarette smoking on endothelial function parameters.
  • To compare endothelial and inflammation markers between smokers and non-smokers with and without coronary atherosclerosis.

Summary:

  • Smoking significantly reduced nitric oxide (NO) levels in both healthy controls and patients with atherosclerosis compared to non-smokers.
  • Patients with coronary atherosclerosis who smoked exhibited elevated levels of interleukin-6 and soluble intercellular adhesion molecule-1 (sICAM).
  • These findings indicate that smoking promotes or sustains inflammatory responses in atherosclerotic blood vessels.

Impact:

  • Highlights the detrimental biochemical impact of smoking on vascular health, particularly in the context of atherosclerosis.
  • Provides evidence for smoking-induced endothelial dysfunction and inflammation, contributing to ischemic heart disease.
  • Underscores the importance of smoking cessation for managing cardiovascular risk and improving endothelial function.

More Related Videos

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...